NU

Neelaveni Uppuganti

Director Director DIN 06434363
DIN 06434363 First appointment Dec 2012 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Neelaveni Uppuganti

Data last updated:

Neelaveni Uppuganti was a Director at Norrish Laboratories Private Limited (2012–2019) and Director at Nm Pharma Private Limited (from 2014). The companies operate in Information Technology.

DIN 06434363
Primary Designation Director
Industry Information Technology
First Appointment 14 Dec 2012
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Norrish Laboratories Private Limited U24233TG2012PTC084835
Director14 Dec 20122012₹20.76 Cr (FY 2024)Active
Nm Pharma Private Limited U33110TG2014PTC093509
Director14 Mar 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nm Pharma Private Limited
Norrish Laboratories Private Limited
Premium access

Shareholding and investment profile for Neelaveni Uppuganti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelaveni Uppuganti

Neelaveni Uppuganti was first appointed on 14 Dec 2012 as Director at Norrish Laboratories Private Limited. The most recent appointment on record is 14 Mar 2014 at Nm Pharma Private Limited.

Neelaveni Uppuganti held 2 earlier board appointments: Norrish Laboratories Private Limited (Director, 14 Dec 2012 to 11 Mar 2019); Nm Pharma Private Limited (Director, from 14 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available